Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration
暂无分享,去创建一个
[1] Li Yang,et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis , 2020, International Journal of Infectious Diseases.
[2] Tao Guo,et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.
[3] Taojiao Wang,et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.
[4] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[5] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[6] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.
[7] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[8] G. Yamanaka,et al. Brain-Derived Neurotrophic Factor and Interleukin-6 Levels in the Serum and Cerebrospinal Fluid of Children with Viral Infection-Induced Encephalopathy , 2014, Neurochemical Research.
[9] A. Karni,et al. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection , 2008, Journal of Neuroimmunology.
[10] A. Karni,et al. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate , 2005, Journal of Neuroimmunology.
[11] H. Scharfman,et al. Mini Review , 2004 .
[12] M. Riva,et al. Cellular Neuroscience Mini Review Article Brain-derived Neurotrophic Factor: a Bridge between Inflammation and Neuroplasticity , 2022 .